Dual GIPR and GLP‐1R agonist tirzepatide inhibits aeroallergen‐induced allergic airway inflammation in mouse model of obese asthma is a research paper published in Clinical & Experimental Allergy (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: 5RO1 AI124456
National Institute of Allergy and Infectious Diseases
Grant: 5RO1 AI145265
National Institute of Allergy and Infectious Diseases
Grant: 5R21 AI145397
National Institute of Allergy and Infectious Diseases
Grant: 2U19 AI095227
U.S. Department of Veterans Affairs
Grant: 5I01BX004299
NIAID NIH HHS
Grant: U19 AI095227
NHLBI NIH HHS
Grant: R01 HL136664
NIAID NIH HHS
Grant: R21 AI145397
NHLBI NIH HHS
Grant: R01 HL122554
NIAID NIH HHS
Grant: R01 AI124456
BLRD VA
Grant: I01 BX004299
NIAID NIH HHS
Grant: R01 AI145265
NIAID NIH HHS
Grant: U01 AI155299
FWCI
1.43
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals